- Home
- TAL vs LNTH Comparison
TAL vs LNTH Comparison
Compare TAL & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAL
- LNTH
- Stock Information
- Founded
- TAL 2003
- LNTH 1956
- Country
- TAL China
- LNTH United States
- Employees
- TAL N/A
- LNTH N/A
- Industry
- TAL Other Consumer Services
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- TAL Real Estate
- LNTH Health Care
- Exchange
- TAL Nasdaq
- LNTH Nasdaq
- Market Cap
- TAL 6.3B
- LNTH 7.5B
- IPO Year
- TAL 2010
- LNTH 2015
- Fundamental
- Price
- TAL $10.34
- LNTH $79.19
- Analyst Decision
- TAL Buy
- LNTH Strong Buy
- Analyst Count
- TAL 4
- LNTH 5
- Target Price
- TAL $13.12
- LNTH $133.80
- AVG Volume (30 Days)
- TAL 6.4M
- LNTH 1.0M
- Earning Date
- TAL 07-31-2025
- LNTH 07-30-2025
- Dividend Yield
- TAL N/A
- LNTH N/A
- EPS Growth
- TAL N/A
- LNTH N/A
- EPS
- TAL 0.14
- LNTH 3.53
- Revenue
- TAL $2,250,233,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- TAL $33.54
- LNTH $4.63
- Revenue Next Year
- TAL $24.09
- LNTH $9.35
- P/E Ratio
- TAL $75.93
- LNTH $22.44
- Revenue Growth
- TAL 50.98
- LNTH 12.53
- 52 Week Low
- TAL $7.35
- LNTH $73.11
- 52 Week High
- TAL $15.30
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- TAL 47.70
- LNTH 44.57
- Support Level
- TAL $10.21
- LNTH $76.34
- Resistance Level
- TAL $10.67
- LNTH $84.36
- Average True Range (ATR)
- TAL 0.27
- LNTH 2.69
- MACD
- TAL -0.03
- LNTH 0.66
- Stochastic Oscillator
- TAL 44.63
- LNTH 48.07
About TAL TAL Education Group
TAL Education Group is a smart learning solutions provider in China. It operates a few business lines including enrichment learning, high school academic tutoring, learning technology, and content solutions. Among those business lines, TAL focuses on enrichment learning and content solutions.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.